Position history for STATE STREET CORP's holdings in IMMUNITYBIO INC
STATE STREET CORP holds 16.5M shares of IBRX (IMMUNITYBIO INC), worth $32.6M as of 2025-Q4. The position was increased (++45.4% shares). IBRX represents 0.0% of STATE STREET CORP's portfolio.
Current Value
$32.6M
Current Shares
16.5M
Total Value Change
-$17.1M
Total Shares Change
+8.6M
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 16.5M |
+45.4% |
| $32.6M |
| 0.0% |
| $1.98 |
39 |
| 2025-Q3 | Increased | 11.3M | +48.6% | $27.8M | 0.0% | $2.57 | 40 |
| 2025-Q2 | Increased | 7.6M | +0.4% | $20.1M | 0.0% | $2.70 | 28 |
| 2025-Q1 | Decreased | 7.6M | -22.5% | $22.8M | 0.0% | $3.14 | 0 |
| 2024-Q4 | Increased | 9.8M | +13.1% | $25.1M | 0.0% | $2.68 | 32 |
| 2024-Q3 | Increased | 8.7M | +10.1% | $32.2M | 0.0% | $3.93 | 32 |
| 2024-Q2 | Decreased | 7.9M | -44.6% | $49.7M | 0.0% | $6.32 | 0 |